Terms: = Thyroid cancer AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK
346 results:
1. Comparative study of imaging and pathology of primary mucinous adenocarcinoma with different imaging manifestations.
Han J; Gao J; Chen D; Du M; Wu Y; Ma X; Xie M; Han H; Wu C; Xue X
Clin Respir J; 2024 Apr; 18(4):e13750. PubMed ID: 38616354
[TBL] [Abstract] [Full Text] [Related]
2. Application research of radiomics in colorectal cancer: A bibliometric study.
Yang L; Wang B; Shi X; Li B; Xie J; Wang C
Medicine (Baltimore); 2024 Apr; 103(15):e37827. PubMed ID: 38608072
[TBL] [Abstract] [Full Text] [Related]
3. Anaplastic and poorly differentiated thyroid carcinomas: genetic evidence of high-grade transformation from differentiated thyroid carcinoma.
Gu H; Wang J; Ran W; Li G; Hu S; Zhao H; Wang X; Wang J
J Pathol Clin Res; 2024 Mar; 10(2):e356. PubMed ID: 38602501
[TBL] [Abstract] [Full Text] [Related]
4. An ultrasound-based nomogram for predicting axillary node pathologic complete response after neoadjuvant chemotherapy in breast cancer: Modeling and external validation.
Zheng Q; Yan H; He Y; Wang J; Zhang N; Huo L; Liu Y; Wang L; Xu L; Fan Z
Cancer; 2024 Apr; 130(S8):1513-1523. PubMed ID: 38427584
[TBL] [Abstract] [Full Text] [Related]
5. Radiation Dose Does Not Affect the Predictive Value of thyroid Biopsy for Diagnosing Papillary thyroid cancer in a Belarusian Cohort Exposed to Chernobyl Fallout.
McConnell RJ; Kamysh O; O'Kane PL; Greenebaum E; Rozhko AV; Yauseyenka VV; Minenko VF; Drozdovitch V; Yarets Y; Kukhta T; Mabuchi K; Little MP; Cahoon EK; Zablotska LB
Acta Cytol; 2024; 68(1):34-44. PubMed ID: 38246154
[TBL] [Abstract] [Full Text] [Related]
6. Patterns of Treatment Failure After Selective Rearranged During Transfection (RET) Inhibitors in Patients With Metastatic Medullary thyroid Carcinoma.
Hadoux J; Al Ghuzlan A; Lamartina L; Bani MA; Moog S; Attard M; Scoazec JY; Hartl D; Aldea M; Friboulet L; Jules-Clement G; Italiano A; Besse B; Lacroix L; Baudin E
JCO Precis Oncol; 2023 Sep; 7():e2300053. PubMed ID: 38127829
[TBL] [Abstract] [Full Text] [Related]
7. The Diagnostic Value of
Cui B; Wu Z; Yu B; Li Y; Liu H
Discov Med; 2023 Dec; 35(179):1064-1070. PubMed ID: 38058071
[TBL] [Abstract] [Full Text] [Related]
8. The correlation between small papillary thyroid cancers and gamma radionuclides Cs-137, Th-232, U-238 and K-40 using spatially-explicit, register-based methods.
Bayadsi H; Brink PVD; Erlandsson M; Gudbjornsdottir S; Sebraoui S; Koorem S; Nordin P; Hennings J; Englund O
Spat Spatiotemporal Epidemiol; 2023 Nov; 47():100618. PubMed ID: 38042537
[TBL] [Abstract] [Full Text] [Related]
9. Characterization of the thyroid cancer Genomic Landscape by Plasma-Based Circulating Tumor DNA Next-Generation Sequencing.
Tarasova VD; Tsai J; Masannat J; Hernandez Prera JC; Hallanger Johnson J; Veloski C; Agosto Salgado S; McIver B; Drusbosky LM; Chung CH
Thyroid; 2024 Feb; 34(2):197-205. PubMed ID: 37962267
[No Abstract] [Full Text] [Related]
10. Diagnostic Performance of thyroid Nodule Risk Stratification Systems: Comparison of ACR-TIRADS, EU-TIRADS, K-TIRADS, and ATA Guidelines.
Yucel S; Balci IG; Tomak L
Ultrasound Q; 2023 Dec; 39(4):206-211. PubMed ID: 37918114
[TBL] [Abstract] [Full Text] [Related]
11. Clinical Outcomes of Radioactive Iodine Redifferentiation Therapy in Previously Iodine Refractory Differentiated thyroid cancers.
Toro-Tobon D; Morris JC; Hilger C; Peskey C; Durski JM; Ryder M
Thyroid; 2024 Jan; 34(1):70-81. PubMed ID: 37917101
[No Abstract] [Full Text] [Related]
12. Therapeutic inhibition of ATR in differentiated thyroid cancer.
Lin SF; Lee YY; Wu MH; Lu YL; Yeh CN; Chen WY; Chou TC; Wong RJ
Endocr Relat Cancer; 2023 Dec; 30(12):. PubMed ID: 37902083
[TBL] [Abstract] [Full Text] [Related]
13. Genetic alterations landscape in paediatric thyroid tumours and/or differentiated thyroid cancer: Systematic review.
de Sousa MSA; Nunes IN; Christiano YP; Sisdelli L; Cerutti JM
Rev Endocr Metab Disord; 2024 Feb; 25(1):35-51. PubMed ID: 37874477
[TBL] [Abstract] [Full Text] [Related]
14. [Correlation between preoperative platelet parameters and clinicopathological features of differentiated thyroid cancer].
Wang X; Liu W; Zhao M
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Oct; 37(10):796-800. PubMed ID: 37828882
[No Abstract] [Full Text] [Related]
15. European Real-World Assessment of the Clinical Validity of a CE-IVD Panel for Ultra-Fast Next-Generation Sequencing in Solid Tumors.
Normanno N; Machado JC; Pescarmona E; Buglioni S; Navarro L; Esposito Abate R; Ferro A; Mensink R; Lambiase M; Lespinet-Fabre V; Calgua B; Jermann PM; Ilié M; Hofman P
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762091
[TBL] [Abstract] [Full Text] [Related]
16. Integrated analysis of tumor microenvironment features to establish a diagnostic model for papillary thyroid cancer using bulk and single-cell RNA sequencing technology.
Wang Y; Song W; Li Y; Liu Z; Zhao K; Jia L; Wang X; Jiang R; Tian Y; He X
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16837-16850. PubMed ID: 37733241
[TBL] [Abstract] [Full Text] [Related]
17. A Detailed Histologic and Molecular Assessment of the Diffuse Sclerosing Variant of Papillary thyroid Carcinoma.
Chou A; Qiu MR; Crayton H; Wang B; Ahadi MS; Turchini J; Clarkson A; Sioson L; Sheen A; Singh N; Clifton-Bligh RJ; Robinson BG; Gild ML; Tsang V; Leong D; Sidhu SB; Sywak M; Delbridge L; Aniss A; Wright D; Graf N; Kumar A; Rathi V; Benitez-Aguirre P; Glover AR; Gill AJ
Mod Pathol; 2023 Dec; 36(12):100329. PubMed ID: 37716505
[TBL] [Abstract] [Full Text] [Related]
18. Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE study.
Bersanelli M; Cortellini A; Leonetti A; Parisi A; Tiseo M; Bordi P; Michiara M; Bui S; Cosenza A; Ferri L; Giudice GC; Testi I; Rapacchi E; Camisa R; Vincenzi B; Caruso G; Rauti AN; Arturi F; Tucci M; Santo V; Ricozzi V; Burtet V; Sgargi P; Todeschini R; Zustovich F; Stucci LS; Santini D; Buti S
Cancer Immunol Immunother; 2023 Nov; 72(11):3707-3716. PubMed ID: 37638980
[TBL] [Abstract] [Full Text] [Related]
19. Fusion Oncogenes in Patients With Locally Advanced or Distant Metastatic Differentiated thyroid cancer.
Ju G; Sun Y; Wang H; Zhang X; Mu Z; Sun D; Huang L; Lin R; Xing T; Cheng W; Liang J; Lin YS
J Clin Endocrinol Metab; 2024 Jan; 109(2):505-515. PubMed ID: 37622214
[TBL] [Abstract] [Full Text] [Related]
20. Transoral endoscopic and robotic thyroidectomy for thyroid cancer: the mid-term oncological outcome.
Chen YH; Chao WP; Wang SH; Huang YT; Ng SC
Surg Endosc; 2023 Oct; 37(10):7829-7838. PubMed ID: 37605012
[TBL] [Abstract] [Full Text] [Related]
[Next]